- Company List - E
- EQ
Insider Trading activities at Equillium, Inc. (EQ)
Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Equillium, Inc. (EQ)
since 2019 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Equillium, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1746466.
Total stock buying since 2019: $0.
Total stock sales since 2019: $3,110,995.
Total stock option exercises since 2019: $273,197.
Table 1. Yearly summary of insider stock purchases, sales, and option exercises
at Equillium, Inc. (EQ).
|
Insider Buying |
Insider Sales |
Option Exercises |
| Year |
Shares | Value |
Shares | Value |
Shares | Value |
| 2025 | 0 | $0 | 10,000 | $6,500 | 0 | $0 |
| 2024 | 0 | $0 | 87,324 | $79,931 | 0 | $0 |
| 2022 | 0 | $0 | 20,000 | $57,850 | 0 | $0 |
| 2021 | 0 | $0 | 83,950 | $556,748 | 77,850 | $273,197 |
| 2020 | 0 | $0 | 318,000 | $2,372,046 | 0 | $0 |
| 2019 | 0 | $0 | 10,000 | $37,920 | 0 | $0 |
Table 2. Monthly summary of insider trading at Equillium, Inc. (EQ).
| Trading Period |
Insider Buying |
Insider Sales |
Option Exercises |
| year-month |
Shares | Value |
Shares | Value |
Shares | Value |
| 2025-01 | 0 | $0 | 10,000 | $6,500 | 0 | $0 |
| 2024-11 | 0 | $0 | 10,000 | $7,000 | 0 | $0 |
| 2024-10 | 0 | $0 | 18,518 | $23,146 | 0 | $0 |
| 2024-09 | 0 | $0 | 48,806 | $41,085 | 0 | $0 |
| 2024-07 | 0 | $0 | 10,000 | $8,700 | 0 | $0 |
| 2022-08 | 0 | $0 | 7,000 | $19,810 | 0 | $0 |
| 2022-06 | 0 | $0 | 5,000 | $12,600 | 0 | $0 |
| 2022-04 | 0 | $0 | 8,000 | $25,440 | 0 | $0 |
| 2021-12 | 0 | $0 | 5,000 | $25,400 | 0 | $0 |
| 2021-11 | 0 | $0 | 11,434 | $62,715 | 23,334 | $57,168 |
| 2021-10 | 0 | $0 | 8,092 | $56,708 | 8,092 | $30,547 |
| 2021-09 | 0 | $0 | 8,000 | $53,928 | 0 | $0 |
| 2021-07 | 0 | $0 | 5,000 | $28,585 | 0 | $0 |
| 2021-06 | 0 | $0 | 46,424 | $329,412 | 46,424 | $185,482 |
| 2020-12 | 0 | $0 | 33,000 | $150,962 | 0 | $0 |
| 2020-09 | 0 | $0 | 25,000 | $140,400 | 0 | $0 |
| 2020-07 | 0 | $0 | 250,000 | $2,033,500 | 0 | $0 |
| 2020-02 | 0 | $0 | 5,000 | $25,139 | 0 | $0 |
| 2020-01 | 0 | $0 | 5,000 | $22,045 | 0 | $0 |
| 2019-09 | 0 | $0 | 5,000 | $17,980 | 0 | $0 |
| 2019-08 | 0 | $0 | 5,000 | $19,940 | 0 | $0 |
Table 3. Detailed insider trading at Equillium, Inc. (EQ)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-01-23 | Keyes Jason A (Chief Financial Officer) | Sale | 10,000 | .65 | 6,500 |
| 2024-11-14 | Keyes Jason A (Chief Financial Officer) | Sale | 10,000 | .70 | 7,000 |
| 2024-10-28 | Tom Penny (Principal Accounting Officer) | Sale | 2,835 | 1.25 | 3,543 |
| 2024-10-28 | Zedelmayer Christine (Sr. Vice President and COO) | Sale | 15,000 | 1.25 | 18,750 |
| 2024-10-25 | Tom Penny (Principal Accounting Officer) | Sale | 683 | 1.25 | 853 |
| 2024-09-26 | Keyes Jason A (Chief Financial Officer) | Sale | 10,000 | .81 | 8,100 |
| 2024-09-16 | Tom Penny (Principal Accounting Officer) | Sale | 38,806 | .85 | 32,985 |
| 2024-07-16 | Keyes Jason A (Chief Financial Officer) | Sale | 10,000 | .87 | 8,700 |
| 2022-08-29 | Keyes Jason A (Chief Financial Officer) | Sale | 7,000 | 2.83 | 19,810 |
| 2022-06-06 | Keyes Jason A (Chief Financial Officer) | Sale | 5,000 | 2.52 | 12,600 |
| 2022-04-04 | Keyes Jason A (Chief Financial Officer) | Sale | 8,000 | 3.18 | 25,440 |
| 2021-12-01 | Keyes Jason A (Chief Financial Officer) | Sale | 5,000 | 5.08 | 25,400 |
| 2021-11-16 | Zedelmayer Christine (Sr. Vice President and COO) | Sale | 11,434 | 5.49 | 62,715 |
| 2021-11-16 | Zedelmayer Christine (Sr. Vice President and COO) | Option Ex | 23,334 | 2.45 | 57,168 |
| 2021-10-06 | Connelly Stephen (Chief Scientific Officer) | Sale | 8,092 | 7.01 | 56,708 |
| 2021-10-06 | Connelly Stephen (Chief Scientific Officer) | Option Ex | 8,092 | 3.77 | 30,547 |
| 2021-09-27 | Keyes Jason A (Chief Financial Officer) | Sale | 8,000 | 6.74 | 53,928 |
| 2021-07-27 | Keyes Jason A (Chief Financial Officer) | Sale | 5,000 | 5.72 | 28,585 |
| 2021-06-08 | Connelly Stephen (Chief Scientific Officer) | Sale | 10,495 | 7.18 | 75,312 |
| 2021-06-08 | Connelly Stephen (Chief Scientific Officer) | Option Ex | 10,495 | 4.75 | 49,851 |
| 2021-06-07 | Connelly Stephen (Chief Scientific Officer) | Sale | 22,390 | 7.11 | 159,260 |
| 2021-06-07 | Connelly Stephen (Chief Scientific Officer) | Option Ex | 22,390 | 3.77 | 84,522 |
| 2021-06-04 | Connelly Stephen (Chief Scientific Officer) | Sale | 13,539 | 7.00 | 94,840 |
| 2021-06-04 | Connelly Stephen (Chief Scientific Officer) | Option Ex | 13,539 | 3.77 | 51,109 |
| 2020-12-28 | Connelly Stephen (Chief Scientific Officer) | Sale | 25,000 | 4.52 | 113,050 |
| 2020-12-23 | Keyes Jason A (Chief Financial Officer) | Sale | 8,000 | 4.74 | 37,912 |
| 2020-09-28 | Connelly Stephen (Chief Scientific Officer) | Sale | 25,000 | 5.62 | 140,400 |
| 2020-07-13 | Connelly Stephen (Chief Scientific Officer) | Sale | 250,000 | 8.13 | 2,033,500 |
| 2020-02-18 | Keyes Jason A (Chief Financial Officer) | Sale | 5,000 | 5.03 | 25,139 |
| 2020-01-21 | Keyes Jason A (Chief Financial Officer) | Sale | 5,000 | 4.41 | 22,045 |
| 2019-09-03 | Keyes Jason A (Chief Financial Officer) | Sale | 5,000 | 3.60 | 17,980 |
| 2019-08-01 | Keyes Jason A (Chief Financial Officer) | Sale | 5,000 | 3.99 | 19,940 |
Insider trading activities including stock purchases, stock sales, and option exercises
of EQ listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Equillium, Inc. (symbol EQ,
CIK number 1746466) see
the Securities and Exchange Commission (SEC) website.